The US stands alone among all other Organization of Economic Cooperation and Development (OECD) nations. That distinction is not good.
Decades of ever-rising healthcare expenditures haven’t led to a concomitant improvement in value, measured in terms of mortality and morbidity outcomes.
Per capita, the U.S. spends more on healthcare than any other OECD nation; more than $11,000 per person annually. But, the U.S. gets a comparatively meager return on its investment of healthcare resources.
See this next paragraph? It won’t happen. It’s not beneficial for the healthcare industry.
Moving forward, health system initiatives – such as improvements to public health, social services, changes in health insurance design, and payment reform – should be judged by whether they move the nation toward higher-value use of resources that translates into improved mortality and morbidity outcomes.